Cleared Special

K071664 - TRELLIS-6 PERIPHERAL INFUSION SYSTEM

K071664 is an FDA 510(k) clearance for TRELLIS-6 PERIPHERAL INFUSION SYSTEM, manufactured by Bacchus Vascular, Inc.. The device is a Class 2 Cardiovascular device with product code QEY cleared through the Special 510(k) pathway after a 25-day FDA review.

K071664 · Bacchus Vascular, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2007
Decision
25d
Days
Class 2
Risk

K071664 is an FDA 510(k) clearance for the TRELLIS-6 PERIPHERAL INFUSION SYSTEM. Classified as Mechanical Thrombolysis Catheter (product code QEY), Class II - Special Controls.

Submitted by Bacchus Vascular, Inc. (Santa Clara, US). The FDA issued a Cleared decision on July 13, 2007 after a review of 25 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5150 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Bacchus Vascular, Inc. devices

FDA 510(k) Submission Details - K071664

510(k) Number K071664 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 18, 2007
Decision Date July 13, 2007
Days to Decision 25 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
100d faster than avg
Panel avg: 125d · This submission: 25d
Pathway characteristics
Modification to existing cleared device.

QEY Device Classification - Class 2, Special Controls

Product Code QEY Mechanical Thrombolysis Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5150
Definition To Mechanically Disrupt Thrombus And/or Debris In The Peripheral Vasculature.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - QEY Mechanical Thrombolysis Catheter

All 49
Devices cleared under the same product code (QEY) and FDA review panel - the closest regulatory comparables to K071664.
ENDOWAVE INFUSION SYSTEM
K072507 · Ekos Corp. · Oct 2007
ENDOWAVE INFUSION SYSTEM
K071933 · Ekos Corp. · Aug 2007
EKOS MICRO-INFUSION SYSTEM
K063620 · Ekos Corp. · Aug 2007
MICRO-INFUSION SYSTEM
K062507 · Ekos Corp. · Nov 2006
LYSUS INFUSION SYSTEM
K060422 · Ekos Corp. · Mar 2006
LYSUS INFUSION SYSTEM
K060084 · Ekos Corp. · Feb 2006